Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
and FDA Commissioner Marty Makary
* Results may vary.
The more you share with your provider, the better they can supervise your treatment and adjust as needed
This can help you get an idea of the quality of the supplier and the medication they are offering
Oral GLP-1s for obesity saw a recent setback when in April (April 2025), Pfizer announced that it was discontinuing development of danuglipron, an oral GLP-1 receptor agonist, which was being investigated for chronic weight management, due to potential liver toxicity
US$ 25.69
US$ 25.54
US$ 27.50
US$ 20.09
US$ 23.70
US$ 24.90
US$ 29.69
US$ 24.51
US$ 20.69
US$ 27.77
US$ 27.25
US$ 25.66
